Biotin-Linked Monoclonal Antibody to Suppression Of Tumorigenicity 14 (ST14)
Ref: CC-LAP657Hu72-200 ul
SNC19; HAI; MT-SP1; PRSS14; TADG15; Epithin; Matriptase; Prostamin; Membrane-type serine protease 1; Serine protease 14; Tumor-associated differentially-expressed gene 15
Información del producto
Información adicional
Size
200 ul
Applications
WB
Detection Range
Cloud Clone
Sensitivity
200 ul
Research Area
Tumor immunity
Immunogen
MAP657Hu21-Monoclonal Antibody to Suppression Of Tumorigenicity 14 (ST14)
Organism species
Homo sapiens (Human)
Alternative Names
SNC19
Item Name
Suppression Of Tumorigenicity 14
Assay Length
Tumor immunity
Sample Type
WB
Host
CHO
Assay procedure summary
Western blotting: 0.5-2ug/ml
Immunocytochemistry in formalin fixed cells: 5-20ug/ml
Immunohistochemistry in formalin fixed frozen section: 5-20ug/ml
Immunohistochemistry in paraffin section: 5-20ug/ml
Enzyme-linked Immunosorbent Assay: 0.0
Immunocytochemistry in formalin fixed cells: 5-20ug/ml
Immunohistochemistry in formalin fixed frozen section: 5-20ug/ml
Immunohistochemistry in paraffin section: 5-20ug/ml
Enzyme-linked Immunosorbent Assay: 0.0
UniProt ID
AAH30532.1
Buffer Formulation
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Usage
Western blotting: 0.5-2ug/ml
Immunocytochemistry in formalin fixed cells: 5-20ug/ml
Immunohistochemistry in formalin fixed frozen section: 5-20ug/ml
Immunohistochemistry in paraffin section: 5-20ug/ml
Enzyme-linked Immunosorbent Assay: 0.0
Immunocytochemistry in formalin fixed cells: 5-20ug/ml
Immunohistochemistry in formalin fixed frozen section: 5-20ug/ml
Immunohistochemistry in paraffin section: 5-20ug/ml
Enzyme-linked Immunosorbent Assay: 0.0
Tissue Source
Antibody labeling